3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

3 FDA Advisory Panel Members Resign Over Agency’s Approval of Alzheimer's Drug From Biogen

Three members of an independent panel that advised the U.S. FDA on nervous system drugs had resigned after the agency approved an Alzheimer's drug from Biogen.
Most Read
  1. Tini Stoessel & Young Miko Aren't Hiding Anymore
  2. First Photos of Gisele Bündchen’s Baby Bump: A Cover-Worthy Mom-to-Be!
  3. The Best Places to Celebrate Halloween in the United States
  4. Tekashi 6ix9ine is Back in the Spotlight After Being Arrested Again—Will He Lose His Record Deal?
Real Time Analytics